CODULLO, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.657
AS - Asia 1.265
EU - Europa 1.193
SA - Sud America 222
AF - Africa 72
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.417
Nazione #
US - Stati Uniti d'America 1.611
CN - Cina 504
SG - Singapore 324
IE - Irlanda 251
DE - Germania 229
BR - Brasile 160
RU - Federazione Russa 159
VN - Vietnam 145
HK - Hong Kong 142
FI - Finlandia 141
FR - Francia 70
IT - Italia 68
AT - Austria 60
GB - Regno Unito 53
IN - India 46
ZA - Sudafrica 44
UA - Ucraina 41
SE - Svezia 34
CA - Canada 31
JP - Giappone 21
AR - Argentina 20
BD - Bangladesh 16
NL - Olanda 16
IQ - Iraq 14
PL - Polonia 14
CO - Colombia 11
CZ - Repubblica Ceca 11
EC - Ecuador 11
MA - Marocco 9
SA - Arabia Saudita 9
BE - Belgio 8
ES - Italia 8
MX - Messico 8
UZ - Uzbekistan 7
VE - Venezuela 7
BO - Bolivia 5
KE - Kenya 5
MY - Malesia 5
CL - Cile 4
ID - Indonesia 4
MK - Macedonia 4
PK - Pakistan 4
TN - Tunisia 4
TR - Turchia 4
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
KR - Corea 2
MU - Mauritius 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 4.417
Città #
Dublin 247
Chandler 227
Singapore 188
Ashburn 169
San Jose 160
Dallas 150
Munich 141
Hong Kong 140
Beijing 118
Helsinki 85
Nanjing 84
Jacksonville 70
Los Angeles 55
Vienna 53
Boardman 49
Ho Chi Minh City 47
Lauterbourg 44
New York 39
Johannesburg 38
Princeton 36
Lawrence 35
Nanchang 34
Shanghai 31
Hanoi 28
Medford 28
Shenyang 27
São Paulo 27
Moscow 26
Wilmington 24
Orem 22
Turku 22
Pavia 21
Buffalo 20
Tokyo 20
Milan 18
Seattle 18
Jiaxing 17
Changsha 15
Council Bluffs 14
Hebei 14
Hangzhou 13
Redondo Beach 13
Ann Arbor 12
Chennai 12
Warsaw 12
London 11
Montreal 11
Amsterdam 10
Da Nang 10
Poplar 10
Santa Clara 10
Brno 9
Denver 9
Haiphong 9
The Dalles 9
Toronto 9
Atlanta 8
Brooklyn 8
Brussels 8
Frankfurt am Main 8
Houston 8
Rio de Janeiro 8
San Francisco 8
Tianjin 8
Woodbridge 8
Chicago 7
Falkenstein 7
Norwalk 7
Pune 7
Stockholm 7
Baghdad 6
Boston 6
Columbus 6
Fairfield 6
Manchester 6
Tashkent 6
Dhaka 5
Guangzhou 5
Jyväskylä 5
Mumbai 5
Nuremberg 5
Phoenix 5
Zhengzhou 5
Biên Hòa 4
Düsseldorf 4
Guayaquil 4
La Paz 4
Medellín 4
Mexico City 4
Paris 4
Berlin 3
Brasília 3
Bến Tre 3
Elk Grove Village 3
Hải Dương 3
Juneau 3
Las Vegas 3
Nairobi 3
Ninh Bình 3
Piscataway 3
Totale 3.006
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 260
B cells in rheumatoid arthritis. 145
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 142
Antinuclear antibodies in systemic sclerosis 137
Disease-related malnutrition in systemic sclerosis: Evidences and implications 134
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 129
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 125
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 123
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 123
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 121
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 118
B cells in rheumatoid arthritis. 118
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 112
Fetal programming and systemic sclerosis 107
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 106
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 103
Association of RNA Polymerase III Antibodies with Scleroderma Renal Crisis reply 103
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 94
An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. 94
Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis 93
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 92
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. 90
Undiagnosed connective tissue diseases High prevalence in pulmonary arterial hypertension patients 89
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials 89
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 88
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors 87
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 87
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 85
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability 84
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 84
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis 84
A 28-Year-Old Man with Stridor and Dyspnea 84
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 83
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy 82
Pathophysiology of systemic sclerosis 82
Stress doppler echocardiography in systemic sclerosis: Evidence for a role in the prediction of pulmonary hypertension 80
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 79
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 77
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 73
Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al 70
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway 63
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 60
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 56
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience 53
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis 52
Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange 35
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 28
Totale 4.503
Categoria #
all - tutte 17.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 15 10 2
2021/2022178 6 1 2 4 0 8 1 6 14 4 26 106
2022/2023688 71 66 12 62 58 68 1 42 273 5 22 8
2023/2024297 34 58 9 15 13 67 13 27 0 22 8 31
2024/2025975 21 45 9 22 15 90 93 81 242 41 102 214
2025/20261.783 147 103 221 227 225 114 329 106 201 110 0 0
Totale 4.503